See also this year's filing and all EDGAR filings for this company.
PDF Report 0001208261_2015_Immune_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001208261, Immune Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 6,887,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 3,415,000 |
| 2 | PropertyPlantAndEquipmentNet | 41,000 |
| 3 | remainder_Assets | 27,521,000 |
| 4 | LiabilitiesCurrent | 7,417,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 12,903,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 9,855,720 |
| 9 | ResearchAndDevelopmentExpense | 5,004,261 |
| 10 | remainder_Expenses | 1,152 |
| 11 | remainder_Revenues | 7,197 |
| 12 | remainder_NetIncome | 3,227,940 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 37,864,000 |
| 1 | Liabilities | 20,320,000 |
| 2 | Expenses | 14,861,133 |
| 3 | Revenues | 7,197 |
| 4 | StockholdersEquity | 17,544,000 |
| 5 | NetIncome | -11,625,996 |
| 6 | ComprehensiveNetIncome | -11,625,996 |
| 7 | BaseVar | 38,140,135 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.915 |
| 9 | EconomicCapitalRatio | 2.23 |
Edgar->Model Mapping
Feature Distribution
Change over Time
